Citation: | YUE Shun. Effects of Sijunzi Decoction on Immunologic Function and Quality of Life in Patients with Rectal Carcinoma After Surgery[J]. Journal of Nanjing University of traditional Chinese Medicine, 2016, 32(4): 334-336. |
[1] |
陆晓,符炜,陆屸,等.结直肠癌根治术后FOLFOX方案辅助化疗的临床疗效[J].江苏医药,2015, 41(15):1804-1806.
|
[2] |
LU X, FU W, LU H, et al. Clinical effects of FOLFOX adjuvant chemotherapy in treating patients with colorectal cancer after radical surgery[J]. Jiangsu Med J, 2015, 41(15) :1804-1806.
|
[3] |
邵棋,葛乃建,杨家和.FOLFOX和FOLFOXIRI方案在结直肠癌肝转移术后患者中的应用[J].肿瘤防治研究,2015, 42(11):1144-1147.
|
[4] |
SHAO Q, GE NJ, YANG JH. FOLFOX and FOLFOXIRI regimens on patients with hepatic metastasis from colorectal cancer after operation[J]. Cancer Res Prev Treat, 2015, 42(11) :1144-1147.
|
[5] |
国家中医药管理局. 中医病证诊断疗效标准[S]. 南京: 南京大学出版社,1994: 186.
|
[6] |
State Chinese Medicine Administration Bureau. Diagnostic Efficacy of Standard TCM Syndrome[S]. Nanjing: Nanjing university press, 1994:186.
|
[7] |
侯风刚,岑怡,贯剑,等.大肠癌脾气虚证辨证量化标准的研究[J].中西医结合学报,2009, 7(9):814-818.
|
[8] |
HOU FG, CEN Y, GUAN J, et al. Quantified diagnostic standard for large intestinal cancer of spleen qi deficiency syndrome[J]. Chin J Integr Med, 2009, 7(9) :814-818.
|
[9] |
中药新药临床研究指导原则(试行)[M].北京:中国医药科技出版社,2004:224,362-363.
|
[10] |
Guiding Principles of Clinical Research on Chinese Traditional Medicine New Drug[M]. Beijing: Chinese medical science and technology press,2004:224,362-363.
|
[11] |
安振涛,苏克雷,王小宁,等.大肠癌中医证型分类研究[J].长春中医药大学学报,2014, 30(6):1108-1110.
|
[12] |
AN ZT, SU KL, WANG XN, et al. Classification study on the TCM syndrome of colorectal cancer[J]. J Changchun Univ Tradit Chin Med, 2014, 30(6): 1108-1110.
|
[13] |
肖寒,杨进.加味四君子汤对大肠癌化疗患者的免疫促进作用[J].中国中西医结合杂志,2011, 31(2):164-167.
|
[14] |
〖JP2〗XIAO H, YANG J. Immune enhancing effect of modified Sijunzi Decoction on patients with colorectal cancer undergoing chemo-therapy[J]. Chin J Integr Tradit West Med, 2011, 31(2) :164-167.〖JP〗
|